Implementing Pathogen Reduced (PR) INTERCEPT Platelets and Pediatric Considerations
Runtime: ~17 minutes
Perspectives on the role that PR plays in meeting the needs of hospitals to deliver timely, safe and efficacious products to meet the needs of pediatric patients from the perspective of a pediatric hematologist-oncologist.
Jennifer Andrews, MD, MSc
Associate Professor of Pathology, Microbiology and Immunology (Division of Transfusion Medicine) and Pediatrics (Division of Hematology/Oncology)
Vanderbilt University Medical Center